Vitru Limited announced that Ms. Mariana Moura Wyatt has been appointed as director. This appointment was made in connection with the previously announced share purchase agreement entered into on August 25, 2023 by and among certain of the company's shareholders, Vinci Capital Partners II J Beta Fundo de Investimento em Participações Multiestratégia, Agresti Investments LLC, Botticelli Investments LLC, Caravaggio Investments LLC, and Raffaello Investments LLC and Dboat I Fundo de Investimento em Participações Multiestratégia (23S) pursuant to which such shareholders agreed to sell 1,875,000 (or, approximately 5.5% of the company's outstanding share capital as of October 25, 2023) to 23S. The director has been appointed by notice by 23S pursuant to Vitru?s amended and articles of association, adopted by special resolution at the ordinary general meeting of shareholders of Vitru held on October 23, 2023.

Ms. Wyatt is a partner and co-founder at 23S Capital. Prior to 23S Capital, Ms. Wyatt worked for 10 years at Temasek, where she was responsible for investments in Brazil. Before Temasek, she worked in the investment banking departments of Goldman Sachs and Citigroup.

She is currently a board member at Bionexo S.A. and Clínica SIM Holdings Ltd. (SiMCo) and a member of the executive committees at Samedil Serviços de Atendimento Médico S.A. (MedSênior). She was also a member of the finance committee of Zamp S.A. (Burger King in Brazil), the strategic committee at Smartfit Escola de Ginástica e Dança S.A. and the risk committee at Superbac Biotechnology Solutions S.A. Ms. Wyatt holds an undergraduate degree in business administration from the Escola de Administração de Empresas de São Paulo da Fundação Getulio Vargas and an MBA from Columbia Business School. Vitru also announced that Mr. Lywal Salles Filho has stepped down from his role as a director of Vitru as well as from all committees and subcommittees of the board.